Cite
HARVARD Citation
Singh, D. et al. (n.d.). A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients. Pulmonary pharmacology & therapeutics. pp. 1-6. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Singh, D. et al. (n.d.). A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients. Pulmonary pharmacology & therapeutics. pp. 1-6. [Online].